Scope and Methodology

• Scope and Segmentation of the Research Service
• Research Methodology

Synopsis of Atrial Fibrillation

• Introduction to the Process of Atrial Fibrillation
• Evaluation and Management of Atrial Fibrillation
• Snapshot of Atrial Fibrillation Treatments

Technology Primer

Key Advances in Therapeutic Agents/Medications

• Atrial Fibrillation--Causes
• Atrial Fibrillation--Symptoms and Diagnosis
• Atrial Fibrillation--Prevention and Treatment

Innovations in Surgical/Catheter-Based Solutions for Atrial Fibrillation

• Phase-3 Global Studies Set off for an Investigational Oral Factor Xa Inhibitor
• Oral Anticoagulant Designed for Enhanced Safety Efficacy
• Investigational Multi-Channel Blocker Significantly Decreased the Risk of Cardiovascular Hospitalizations in AF Patients
• Unique Anticoagulant that Provides Predictable Anticoagulation Combined with a Lower Risk of Bleeding
• Add-on Therapy for the Reduction of New Onset Atrial Fibrillation
• Investigational Drug Being Evaluated for the Acute Conversion of Atrial Fibrillation
• Picomolar Concentrations of Two Novel Peptide Agonists Demonstrated Reduction in AF Incidence
• Osteoporosis Drug Fosamax Linked to Chronic Irregular Heart Beat Incidence
• Gene Defect Tied to Atrial Fibrillation

Insights:Technology-Imperative Factors

Analyst Insights and Strategic Recommendations

Patent Details

Key Contacts

Database Tables